top of page
reBalans wide.jpg

Introducing Re:Balans® 

a wearable device for hydration monitoring

Our Innovation Partners

This project has received funding from the European Union's Horizon 2020 research and development program under grant agreement No 969065.

EIC - LOGO 2021.png
InnoMed.png
Innovasjon-Norge-logo.png
AdolfØiensFond2.jpg
Eurostars_Circle-298x300_edited.png
InnoMed-logo.png
Eit Health.png
Regionale-Forskningsfond.png
Forskningsradet-logo.png
social_edited.jpg
Skjermbilde 2023-03-20 kl. 15.17_edited.jpg

This project has also received funding from the European Union's Horizon cybersecurity research and development program under grant agreement No 101094323 - NEMECYS, together with SINTEF.

Despite its importance in monitoring patients with fluid management conditions, identifying an effective approach continues to present a challenge in the field of medicine.
 

Re:Balans is currently only available for clinical investigations and research purposes, and are not yet cleared for medical use in the EU or US. 

“This technology represents the future of fluid monitoring”

Dr. Solfrid Romunstad, Chief Nephrologist (Helse Midt)

R&d.jpg

5 years of R&D 

The development of Re:Balans has been challenging and requires a dedicated team of developers, researchers, and over $10M in funding. Currently, we are in the process of seeking regulatory approval in US and Europe. 

Mode

DSC09158.JPG

Mode In Numbers

14

Employees

5

Years of dev

10M$

Capital invested

10+

Partners

CAREERS

We’re looking for innovative talent to join our team. See all positions and submit your CV.

Get in Touch

Thanks for submitting!

bottom of page